Agranulocytosis, acquired (DC 7702) | VA Rating Tool
| Diagnostic Code | 7702 |
|---|---|
| Category | The Hemic and Lymphatic Systems |
| Subcategory | The Hematologic and Lymphatic Systems |
| Also Known As | Agranulocytosis, acquired, non-Hodgkin lymphoma, NHL, lymphoma, cancer |
| CFR Section | 4.117 |
Next Steps for This Condition
Rating Criteria
| Rating | Criteria |
|---|---|
| 100% | Requiring bone marrow transplant; or infections recurring, on average, at least once every six weeks per 12-month period |
| 60% | Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain absolute neutrophil count (ANC) greater than 500/microliter (µl) but less than 1000/µl; or infections recurring, on average, at least once every three months per 12-month period |
| 30% | Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl; or infections recurring, on average, at least once per 12-month period but less than once every three months per 12-month period |
| 10% | Requiring continuous medication (e.g., antibiotics) for control; or requiring intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/µl |